Instagram and Podcast Intervention for Breast Cancer Awareness and Screening
The Effect of an Instagram- and Podcast-Based Intervention on Women's Breast Cancer Awareness, Health Beliefs, and Screening Behaviors: A Randomized Controlled Trial
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Breast cancer is the most frequently diagnosed cancer among women worldwide and remains a major public health concern. Early detection through screening is essential for reducing breast cancer-related morbidity and mortality. However, many women continue to experience barriers to screening participation, including limited awareness, insufficient knowledge, low perceived susceptibility, fear of diagnosis, and inadequate health beliefs regarding breast cancer and its screening methods.
Digital health interventions have emerged as accessible and cost-effective approaches for delivering health education and promoting preventive health behaviors. Social media platforms, particularly Instagram, are widely used by young women and offer an effective channel for disseminating health-related information. Podcasts provide an additional narrative-based educational approach that may enhance engagement, improve information retention, and support behavior change through emotionally meaningful content.
This randomized controlled trial aims to evaluate the effectiveness of an Instagram- and podcast-based intervention in improving breast cancer awareness, health beliefs, and screening behaviors among women aged 20-39 years. Participants in the intervention group will receive evidence-based educational content through Instagram posts and podcasts, while the control group will receive no intervention during the study period. Outcomes will include breast cancer awareness, health beliefs related to breast cancer screening, and screening behaviors such as breast self-examination practices.
The findings of this study are expected to provide evidence regarding the effectiveness of combined social media and podcast-based interventions as scalable, low-cost strategies for promoting breast cancer awareness and encouraging preventive screening behaviors among women.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Baise BİCAV
- Numéro de téléphone: 0 312 329 10 10
- E-mail: baisebicav@gmail.com
Sauvegarde des contacts de l'étude
- Nom: Zehra BİCAV
- Numéro de téléphone: 0 312 329 10 10
Lieux d'étude
-
-
-
Ankara, Turquie (Türkiye)
- Recrutement
- Ankara
-
Contact:
- Baise Bicav
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
- Women aged 20-39 years
- Able to read and write Turkish
- Turkish citizens
- Have an active Instagram account and access it at least once daily
- No previous diagnosis of cancer
- Willing to participate and provide informed consent
Exclusion Criteria:
- No access to a smartphone with the Instagram application
- Visual, hearing, or cognitive impairment that may prevent participation in the intervention
Withdrawal Criteria:
- Failure to complete the assigned podcast sessions during the intervention period
- Participant request to withdraw from the study at any time
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Dépistage
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Instagram Group
Participants will receive an 8-week Instagram-based breast cancer awareness intervention.
|
Participants will follow the "Breast Health Academy" Instagram account and receive an 8-week Instagram-based breast cancer awareness intervention.
Educational breast cancer awareness and screening content will be shared as posts and stories on Mondays, Wednesdays, and Saturdays.
Reminder stories encouraging breast self-examination (BSE), such as "Do not forget to perform your monthly BSE" and "Remember to perform BSE this week," will be shared on Tuesdays, Thursdays, and Sundays.
Stories will also be saved as highlights.
No content will be shared on Fridays, and all posts and stories will be published at the same time each day.
|
|
Expérimental: Instagram + Podcast Group
Participants will receive an 8-week Instagram- and podcast-based breast cancer awareness intervention.
|
Participants will follow the "Breast Health Academy Plus" Instagram account and receive an 8-week Instagram- and podcast-based breast cancer awareness intervention.
Educational breast cancer awareness and screening content will be shared as posts and stories on Mondays, Wednesdays, and Saturdays.
Reminder stories encouraging breast self-examination (BSE) will be shared on Tuesdays, Thursdays, and Sundays and saved as highlights.
In addition, one educational podcast episode developed for the intervention will be delivered weekly via Instagram direct message every Friday.
All content will be provided at the same time each day throughout the intervention period.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Breast Cancer Awareness Scale
Délai: Assessments will be performed at baseline and Week 8.
|
The Breast Cancer Awareness Measure assesses awareness of breast cancer symptoms, breast self-examination practices, and age-related risk perception.
Total scores range from 0 to 3, with higher scores indicating greater breast cancer awareness.
|
Assessments will be performed at baseline and Week 8.
|
|
Champion's Health Belief Model Scale in Breast Cancer Screening
Délai: Assessments will be performed at baseline and Week 8.
|
The Champion's Health Belief Model Scale (CHBMS) for Breast Cancer Screening is a validated instrument used to assess health beliefs related to breast cancer screening.
The Turkish version consists of six subscales: perceived susceptibility (3 items), perceived seriousness (6 items), health motivation (5 items), perceived benefits of breast self-examination (BSE) (4 items), perceived barriers to BSE (8 items), and BSE self-efficacy/confidence (10 items).
Each subscale is evaluated separately, and no total score is calculated.
Higher scores on the perceived susceptibility, perceived seriousness, health motivation, BSE benefits, and BSE self-efficacy/confidence subscales indicate stronger health beliefs, whereas higher scores on the BSE barriers subscale indicate greater perceived barriers to breast cancer screening and breast self-examination.
|
Assessments will be performed at baseline and Week 8.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Participant Satisfaction (VAS)
Délai: Assessed at Week 8.
|
Participant satisfaction with the Instagram- and podcast-based intervention will be assessed using a 0-10 Visual Analog Scale (VAS), where 0 indicates "not satisfied at all" and 10 indicates "extremely satisfied."
|
Assessed at Week 8.
|
|
Breast Cancer Screening Behavior Questionnaire
Délai: Assessments will be performed at baseline and Week 8.
|
Breast Cancer Screening Behavior Questionnaire.
A researcher-developed 3-item questionnaire assessing breast cancer screening behaviors, including breast self-examination within the previous month, clinical breast examination by a healthcare professional, and mammography uptake or scheduling.
Each item is recorded as Yes or No and analyzed separately.
No total score is calculated; therefore, minimum and maximum scores are not applicable.
|
Assessments will be performed at baseline and Week 8.
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Baise Bicav, Yuksek Ihtisas University
- Chercheur principal: Zehra Bicav, Yuksek Ihtisas University
- Directeur d'études: Sevinç Kutlutürkan, Ankara University
- Directeur d'études: Filiz Ünal Toprak, Saglik Bilimleri Universitesi
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- AU-HEM-BB-02
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .